PH11 is a focal adhesion kinase (FAK) inhibitor that, in combination with TRAIL, rapidly induces apoptosis in TRAIL-resistant PANC-1 pancreatic cancer cells without affecting normal human fibroblasts; it downregulates c-FLIP by inhibiting the FAK and phosphatidylinositol-3-kinase (PI3K)/AKT pathways, thereby restoring the TRAIL-mediated apoptotic pathway and offering a promising strategy for the safe and effective treatment of pancreatic cancer; PH11 represents an innovative approach to selectively suppress c-FLIP expression through modulation of upstream signaling pathways, providing a novel method to overcome TRAIL resistance without interfering with caspase-8 processing.